Qualifier English: | Antirheumatic Agents | ||||||
Qualifier Spanish: |
Antirreumáticos
| ||||||
Qualifier Portuguese: | Antirreumáticos | ||||||
Qualifier French: | Antirhumatismaux | ||||||
Entry term(s): |
Agent, Anti-Rheumatic Agent, Antirheumatic Anti Rheumatic Agent Anti Rheumatic Agents Anti Rheumatic Agents, Non Steroidal Anti Rheumatic Drug Anti Rheumatic Drugs Anti-Rheumatic Agent Anti-Rheumatic Agents Anti-Rheumatic Agents, Non-Steroidal Anti-Rheumatic Drug Anti-Rheumatic Drugs Antirheumatic Agent Antirheumatic Disease Modifying Second Line Drug Antirheumatic Disease Modifying Second Line Drugs Antirheumatic Disease-Modifying Second-Line Drug Antirheumatic Disease-Modifying Second-Line Drugs Antirheumatic Drug Antirheumatic Drug, Disease-Modifying Antirheumatic Drugs Antirheumatic Drugs, Disease Modifying Antirheumatic Drugs, Disease-Modifying DMARD Disease Modifying Antirheumatic Drug Disease Modifying Antirheumatic Drugs Disease Modifying, Antirheumatic Second Line Drugs Disease-Modifying Antirheumatic Drug Disease-Modifying Antirheumatic Drugs Disease-Modifying, Antirheumatic Second-Line Drugs Drug, Anti-Rheumatic Drug, Antirheumatic Drug, Disease-Modifying Antirheumatic Non-Steroidal Anti-Rheumatic Agents |
||||||
Tree number(s): |
D27.505.954.329 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D018501 | ||||||
Scope note: | Drugs that are used to treat RHEUMATOID ARTHRITIS. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Public MeSH Note: | 95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94 |
||||||
Online Note: | use ANTI-INFLAMMATORY AGENTS to search ANTI-RHEUMATIC AGENTS 1987-94 |
||||||
History Note: | 95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94 |
||||||
Related: |
Antimalarials
MeSH Immunosuppressive Agents MeSH | ||||||
DeCS ID: | 32355 | ||||||
Unique ID: | D018501 | ||||||
NLM Classification: | QV 247 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1995/01/01 | ||||||
Date of Entry: | 1994/06/01 | ||||||
Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
Antirheumatic Agents
- Preferred
Antirheumatic Drugs, Disease-Modifying
- Narrower
Anti-Rheumatic Agents, Non-Steroidal
- Narrower
Concept UI |
M0027742 |
Scope note | Drugs that are used to treat RHEUMATOID ARTHRITIS. |
Preferred term | Antirheumatic Agents |
Entry term(s) |
Agent, Anti-Rheumatic Agent, Antirheumatic Anti Rheumatic Agent Anti Rheumatic Agents Anti Rheumatic Drug Anti Rheumatic Drugs Anti-Rheumatic Agent Anti-Rheumatic Agents Anti-Rheumatic Drug Anti-Rheumatic Drugs Antirheumatic Agent Antirheumatic Drug Antirheumatic Drugs Drug, Anti-Rheumatic Drug, Antirheumatic |
Concept UI |
M0027743 |
Preferred term | Antirheumatic Drugs, Disease-Modifying |
Entry term(s) |
Antirheumatic Disease Modifying Second Line Drug Antirheumatic Disease Modifying Second Line Drugs Antirheumatic Disease-Modifying Second-Line Drug Antirheumatic Disease-Modifying Second-Line Drugs Antirheumatic Drug, Disease-Modifying Antirheumatic Drugs, Disease Modifying DMARD Disease Modifying Antirheumatic Drug Disease Modifying Antirheumatic Drugs Disease Modifying, Antirheumatic Second Line Drugs Disease-Modifying Antirheumatic Drug Disease-Modifying Antirheumatic Drugs Disease-Modifying, Antirheumatic Second-Line Drugs Drug, Disease-Modifying Antirheumatic |
Concept UI |
M000633957 |
Preferred term | Anti-Rheumatic Agents, Non-Steroidal |
Entry term(s) |
Anti Rheumatic Agents, Non Steroidal Non-Steroidal Anti-Rheumatic Agents |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey